《新股消息》京東健康(06618.HK)明起招股 入場費3,564.56元
京東(09618.HK)就分拆京東健康(06618.HK)在港上市公布招股詳情,計劃發售3.819億股,當中5%即約1,909.5萬股為本地公開發售,95%即約3.63億股為國際配售,另有15%超額配股權。招股價介乎62.8至70.58元,集資最多約269.6億元,未計手續費每手50股,入場費約3,564.56元。
京東健康將於本周四(26日)起至下周二(12月1日)招股,預期12月8日掛牌上市,聯席保薦人為美銀、海通國際及瑞銀。
是次招股將引入Hillhouse、Tiger Global、Lake Bleu Prime、中國國有企業結構調整基金、新加坡政府投資公司GIC及BlackRock為基石投資者。
以招股價中位數每股66.69元計,所得款項淨額約為249.94億元,約40%用於在未來36至60個月業務擴張;約30%用於在未來24至36個月研發;約20%用於潛在投資及收購或成立戰略聯盟;餘下約10%為一般營運資金。(gc/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.